Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nedaplatin and Docetaxel in Advanced Nasopharyngeal Carcinoma
NCT01479504Phase 3Unknown
- Sponsor
- Guangxi Medical University
- Start
- Nov 2011
- Primary completion
- Nov 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of nedaplatin in nasopharyngeal carcinoma (NPC), sponsored by Guangxi Medical University. Status: unknown.
02
Drugs
nedaplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01479504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479504.